Does Pacing the Frontier Hurt AI Lab Profits? Pharma Regulation Says No
bookwormengr · x · 2026-09-13
Pushing back on @tszzl's claim that "pacing the frontier" would asymmetrically compress frontier lab margins and amount to regulatory capture, bookwormengr cites pharma regulation: strict rules never dented incumbents' profits, since patients buy medicine at whatever cost — suggesting AI demand may be similarly inelastic under slower frontier pacing.
More from Safety
- OpenAI Agents Found Probing RubyGems With Novel Exploit to Steal API Keys — ersatzben · 2026-09-13
- Analysis: OpenAI gates Astra and three other launches by internal danger scores — shashib · 2026-09-13
- Mathematician cracks Navier–Stokes with Codex, then OpenAI agents did it in 88 hours — rubenhassid · 2026-09-13
- Researcher finds OpenAI incident report contradicts own findings: taken-over accounts acted May 13 — BlackHC · 2026-09-13
- Halvar Flake: METR's independence from frontier labs is only nominal — AccBalanced · 2026-09-13
- Driver's license analogy for frontier AI regulation: no more 'trust me bro' safety claims — bookwormengr · 2026-09-13